Early Diagnosis

Since newly approved treatments can specifically inhibit further deposition of amyloid material, early diagnosis of cardiac involvement in transthyretin amyloidosis (ATTR) before appearance of left ventricular hypertrophy is advisable. Read Article ›

Endomyocardial biopsy is recommended for TTR cardiac amyloidosis diagnosis in elderly patients, based on false-positive bone scintigraphy case. Read Article ›

Improving nurses’ knowledge of specific cardiovascular symptoms may enhance clinical suspicion resulting in early diagnosis of hereditary transthyretin amyloidosis and prompt intervention. Read Article ›

Early diagnosis of ATTRv may facilitate early treatment initiation with disease-modifying therapy. Read Article ›

Case study of a 79-year-old African American female, who presented with an exacerbation of congestive heart failure, highlights the importance of diagnosis, treatment, and genetic testing. Read Article ›

Analysis of subtypes of pulmonary hypertension, and potential association with specific biomarkers and survival, suggests further studies are required. Read Article ›

While fat pad or myocardial biopsy remains the gold standard for hATTR diagnosis, this case study highlights the potential of using tendon tissue. Read Article ›

Early diagnosis of hereditary ATTR may facilitate early treatment initiation with disease-modifying therapy. Read Article ›

At the time of common orthopedic surgeries, amyloid deposition can be detected, especially in patients aged ≥70 years, providing clinicians with an opportunity for early diagnosis. Read Article ›

This case study highlights the importance of careful evaluation when determining whether a patient has AL or ATTR cardiac amyloidosis. Read Article ›

Page 3 of 5

Amyloidosis News
Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News by subscribing to receive the free AMN e‑Newsletter.